RHABDOMYOLYSIS-CLINICAL & INX
From NeuroRehab.wiki
Revision as of 11:48, 31 January 2023 by Dr Appukutty Manickam (talk | contribs) (Imported from text file)
SUMMARY
1. Patients present as a result of the underlying cause and/or with muscle pain and cola-colored urine.
2. Labs show increased CPK (> 100,000 IU/L) with nonspecific increases in AST and ALT.
3. Hyperkalemia, hyperphosphatemia, increased uric acid, and hypocalcemia are common complications.
4. U/A shows muddy brown casts consistent with ATN.
Reference(s)
Wilkinson, I. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].
